The House of Representatives passed a bill aimed at preempting state-level mandates for labels on foods derived from crops improved through biotechnology, or “GMOs,” writes Val Giddings in Innovation Files.

For the sake of both future global innovation and for the interests of consumers and patients worldwide, we must stay the course on robust IP protections in the Trans-Pacific Partnership, writes Stephen Ezell in The Hill.

U.S. and EU policymakers will have to get data privacy and trade policies right if they want to maximize the growth potential of the transatlantic marketplace, writes Stephen Ezell in Innovation Files.

The public and private sectors need to work in tandem to realize the next generation of medicine and health care and overcome the institutional challenges that increasingly hinder progress toward precision medicine.